Ads
related to: hemophilia a in adults- Cost And Coverage
Information On Financial Programs &
Aid For Patients With Hemophilia A.
- Pharmacology Information
Find More Information About
a Treatment Option.
- Dosing & Administration
Information on Dosing,
Reconstitution and Administration.
- Physician Resources
Professional Educational Resources
On A Hemophilia A Treatment Option.
- Prophylaxis Information
Keep Your Patients With
Hemophilia A Protected From Bleeds.
- Dosing And Administration
Information For HCPs On Dosing,
Reconstitution and Administration.
- Cost And Coverage
Search results
Results From The WOW.Com Content Network
Joint capsule. Haemophilia A's phenotype has a quite wide range of symptoms encompassing both internal and external bleeding episodes. Individuals with more severe haemophilia tend to experience more intense and frequent bleeding, whereas those with mild haemophilia typically exhibit milder symptoms unless subjected to surgical procedures or significant trauma.
In the United States, valoctocogene roxaparvovec is indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency with factor VIII activity < 1 IU/dL) without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test.
Efanesoctocog alfa is a recombinant DNA-derived, Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes; on-demand treatment & control of bleeding episodes; and perioperative management of bleeding.
Hemophilia A affects about 25 in every 100,000 male births worldwide, according to data cited by Pfizer, with majority of them having a moderate to severe form of the disease for which the gene ...
Acquired haemophilia A (AHA) is a rare but potentially life-threatening bleeding disorder characterized by autoantibodies directed against coagulation factor VIII. These autoantibodies constitute the most common spontaneous inhibitor to any coagulation factor and may induce spontaneous bleeding in patients with no previous history of a bleeding ...
Haemophilia C is an autosomal genetic disorder involving a lack of functional clotting Factor XI. Haemophilia C is not completely recessive, as heterozygous individuals also show increased bleeding. [42] The type of haemophilia known as parahaemophilia is a mild and rare form and is due to a deficiency in factor V.
Ad
related to: hemophilia a in adults